These aren't the glory days for med-tech giant Medtronic (NYSE: MDT ), as fiscal 2014 will be a pretty weak year from a growth perspec...

These aren't the glory days for med-tech giant Medtronic (NYSE: MDT ), as fiscal 2014 will be a pretty weak year from a growth perspec...
In a sell-side world where Underperform/Sell ratings are pretty rare, is a bit of exception, as several analysts have either recommended th...
When AngioDynamics ( ANGO ) reported last night, it brought a challenging fiscal year to close for this small med-tech company. A combina...
At the risk of sounding a bit mean, CareFusion (NYSE: CFN ) doesn't get all that much attention in the market. The company has a soli...
Combine a bull market with increasing optimism that major med-tech markets are stabilizing, and it's not so hard to see why stocks like...
Medical technology stocks of all stripes have been enjoying a pretty exceptional run in the market, as healthcare has actually been 1 of th...
Although I had been writing for some time that I thought Edwards Lifesciences (NYSE: EW) was significantly overvalued by the market, I do...
I've been relatively optimistic about St. Jude Medical 's (NYSE: STJ ) long-term prospects as the company navigates its current mul...